| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |